August 20, 2019 08:58 AM EDT

Elanco to buy Bayer's animal health business for $7.6B, as dealmaking gathers steam in the sector

Natalie Grover

Reporter

Last week, Elanco explicitly dodged answering questions about its rumored interest in Bayer’s animal health business in its post-earnings call. On Tuesday, the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Elanco to buy Bayer's animal health business for $7.6B, as dealmaking gathers steam in the sector

Natalie Grover

Reporter

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

CBER's deputy director departs as staff shakeup continues

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Will CRISPR matter?

FDA approves first drug to treat ultra-rare lipid storage disease

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Elan­co to buy Bay­er's an­i­mal health busi­ness for $7.6B, as deal­mak­ing gath­ers steam in the sec­tor

Reporter

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Elanco to buy Bayer's animal health business for $7.6B, as dealmaking gathers steam in the sector